483 Eli Lilly & Company May 2003

483 Eli Lilly & Company May 2003

Jean Blackston Hill FDA, Susan Bruederle FDA, Susan Laska FDA, Raymond Oji FDA, Jeffrey Sommers FDA$119.00 - Available Now

FDA investigators audited the Eli Lilly & Company - Indianapolis, IN, United States facility and issued inspectional observations (via FDA 483) on 29 May 2003.

Product details

  • Category: Human Drugs / Animal Drugs & Feeds
  • Inspection end: 29 May 2003
  • Location: Indianapolis, United States
  • FEI: 1819470
Add To Cart